CARMA study is entering the final stage of enrollment

16 Feb, 2018

We are happy to announce that the enrollment into the CARMA study is moving fast with 31 patients enrolled out of a target of 40 patients. Thanks all sites for their committment!

CARMA is a a multi-centre, cross-sectional study of children with perinatally acquired HIV-1 on sustained suppressive antiretroviral therapy started before 2 years of age. It is part of the EPIICAL project, which is financed by ViiV Healthcare U.K. (ViiV).